CompletedNCT02087579
Blood Levels of Five Antipsychotic Medicines in People Receiving Psychiatric Care
About this title
Read the official source — NCT02087579Medication studyAges 18–70Multiple countriesSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- Garden Grove and 23 more locationsSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateFebruary 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 305
- Sponsor
- Janssen Research & Development, LLC
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States, Belgium, Argentina, ...
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT02087579
- Official title
Show the full official title
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Garden Grove, United States · Kissimmee, United States · Atlanta, United States
21 more locations
- Hoffman Estates, United States
- Cedarhurst, United States
- Austin, United States
- Banfield, Argentina
- Buenos Aires, Argentina
- Córdoba, Argentina
- La Plata, Argentina
- Aalst, Belgium
- Antwerp, Belgium
- Brussels, Belgium
- Kortenberg, Belgium
- Rio de Janeiro, Brazil
- Valinhos, Brazil
- Burgas, Bulgaria
- Berlin, Germany
- Hamburg, Germany
- Lübeck, Germany
- Badajoz, Spain
- Barcelona, Spain
- Torrevieja, Spain
- Zamora, Spain
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Janssen Research & Development, LLC.
Did this study involve medication?
Yes. The study involved medication, including Aripiprazole, oral formulation, Olanzapine, oral formulation, Paliperidone, oral formulation, Paliperidone, LAI, Quetiapine, oral formulation, Risperidone, oral formulation and Risperidone, LAI.
Who was this study for?
Listed age limits: 18 years to 70 years.
Want to explore more studies?
Explore studiesRelated studies
A randomized controlled clinical trial for assessing the effectiveness of pharmacogenetic information obtained with NEUROFARMAGEN in the treatment of patients with mental disorders
A Study of SEP-380135 in Adults With Schizophrenia or Major Depressive Episode